P

Inventor

RUDOLPH MARKUS

CH37 patents
⚠️ This page may combine multiple inventors who share the name “RUDOLPH MARKUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

25 patents
US9802944B2Oct 31, 2017

Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors

HOFFMANN LA ROCHE20 citations92
US10669285B2Jun 2, 2020

Condensed [1,4] diazepine compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors

HOFFMANN LA ROCHE9 citations84
US10654857B2May 19, 2020

Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors

HOFFMANN LA ROCHE10 citations84
US10640472B2May 5, 2020

Phenoxymethyl derivatives

HOFFMANN LA ROCHE10 citations84
US10647719B2May 12, 2020

Bicyclic compounds as dual ATX/CA inhibitors

HOFFMANN LA ROCHE10 citations83
US9394311B2Jul 19, 2016

Triazolo compounds as PDE10 inhibitors

HOFFMANN LA ROCHE7 citations82
US11098048B2Aug 24, 2021

Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors

HOFFMANN LA ROCHE2 citations73
US10849881B2Dec 1, 2020

Octahydro-cyclobuta[1,2-c;3,4-c′]dipyrrol-2-yl

HOFFMANN LA ROCHE3 citations73
US10889588B2Jan 12, 2021

Bicyclic compounds as dual ATX/CA inhibitors

HOFFMANN LA ROCHE3 citations72
US10800786B2Oct 13, 2020

Bicyclic compounds as ATX inhibitors

HOFFMANN LA ROCHE4 citations72
US10787459B2Sep 29, 2020

Bicyclic compounds as ATX inhibitors

HOFFMANN LA ROCHE4 citations72
US10738053B2Aug 11, 2020

Bicyclic compounds as dual ATX/CA inhibitors

HOFFMANN LA ROCHE5 citations72
US10882857B2Jan 5, 2021

Bicyclic compounds as ATX inhibitors

HOFFMANN LA ROCHE3 citations71
US11059794B2Jul 13, 2021

Heterocyclic compounds useful as dual ATX/CA inhibitors

HOFFMANN LA ROCHE2 citations69
US11352330B2Jun 7, 2022

Phenoxymethyl derivatives

HOFFMANN LA ROCHE1 citations62
US9199938B2Dec 1, 2015

Aryl-quinoline derivatives

HOFFMANN LA ROCHE2 citations62
US8017604B2Sep 13, 2011

Imidazopyridines

HOFFMANN LA ROCHE3 citations62
US11673888B2Jun 13, 2023

Bicyclic compounds as ATX inhibitors

HOFFMANN LA ROCHE0 citations61
US11001555B2May 11, 2021

Difluoroketamide derivatives as HTRA1 inhibitors

HOFFMANN LA ROCHE0 citations52
US9809599B2Nov 7, 2017

Aryl-quinoline derivatives

HOFFMANN LA ROCHE0 citations52
US10435407B2Oct 8, 2019

Triaza-spirodecanones as DDR1 inhibitors

HOFFMANN LA ROCHE0 citations50
US10239876B2Mar 26, 2019

Triaza-spirodecanones as DDR1 inhibitors

HOFFMANN LA ROCHE0 citations50
US10870623B2Dec 22, 2020

Trifluoromethylpropanamide derivatives as HTRA1 inhibitors

HOFFMANN LA ROCHE0 citations41
US10865182B2Dec 15, 2020

Difluoroketamide derivatives as HtrA1 inhibitors

HOFFMANN LA ROCHE0 citations41
US9656971B2May 23, 2017

COMT inhibitors

HOFFMANN LA ROCHE0 citations38

ALBERATI DANIELA

3 patents

ROEHM GMBH

2 patents

RUDOLPH MARKUS

2 patents

BENSON GREGORY MARTIN

2 patents

NOVARTIS AG

1 patent

BACHMANN STEPHAN

1 patent

ALVAREZ SANCHEZ RUBEN

1 patent